Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Rheumatoid Arthritis (RA)
Clinical trial register · United States · industry-sponsored

Rheumatoid Arthritis (RA) Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9129 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 03 Nov 2026, 03:16 UTC
9129
Studies in scope
industry-sponsored, all four open statuses
4971
Recruiting now
open to new participants
2191
Lead sponsors
across recruiting studies
Top states
California 4 Florida 4 Massachusetts 3 Arizona 3 Colorado 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Rheumatoid Arthritis (RA) trials in the USA

11 of 9129 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
FT839 in Autoimmune Diseases
NCT07800871ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE)
Fate Therapeutics
Phase 1/2
446
California
2026-10
Not yet open
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
NCT07729995Rheumatoid Arthritis (RA), Systemic Lupus Erthematosus (SLE), Dermatomyositis (DM), Systemic Sclerosis (SSc)
Luminary Therapeutics
Phase 1
94
Massachusetts
2026-10
Recruiting
Eli Lilly and Company
Phase 1
141
Alabama, Arizona, Florida, Nevada
2025-12-02
Recruiting
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
NCT07403188Refractory Lupus Nephritis, Myasthaenia Gravis, Stiff Person Syndrome, Rheumatoid Arthritis (RA)
Kyverna Therapeutics
Observational
70
Colorado
2025-11-24
Active, closed
Probiotics in Adults With Rheumatoid Arthritis
NCT07304505Rheumatoid Arthritis (RA)
Ancilia Biosciences
Not applicable
50
Illinois
2025-11-13
Active, closed
SecondWave Systems Inc.
Not applicable
60
Arizona, California, Colorado, Minnesota
2025-11-03
Recruiting
Sonoma Biotherapeutics, Inc.
Observational
36
California, Colorado, Illinois, Massachusetts, Minnesota, North Carolina, Texas
2025-07-22
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
NCT06991114Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA
Artiva Biotherapeutics, Inc.
Phase 2
90
Alabama, Arizona, California, Florida, Georgia, Illinois, Iowa, Montana
2025-07-09
Active, closed
Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis
NCT06628206Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA)
LAPIX Therapeutics Inc.
Phase 1
48
Florida, North Dakota, Pennsylvania, Texas
2024-12-15
Active, closed
Food Trial to Evaluate the Kinetics of the Medical Foods SBD111 and SBD121 Persistence in Healthy Adults
NCT06614166Product Persistence in GI Tract, Kinetics, Rheumatoid Arthritis (RA), Bone Density
Solarea Bio, Inc
Not applicable
40
Massachusetts
2024-06-14
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 3 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/rheumatoid-arthritis-ra

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,129 studies in total at the last sync on 03 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies listing the condition Rheumatoid Arthritis (RA).

How many Rheumatoid Arthritis (RA) trials are recruiting in the US?

6 of the 11 studies on this page are recruiting new participants as of the 03 Nov 2026, 03:16 UTC sync. A further 1 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Rheumatoid Arthritis (RA)), 11 studies
PhaseStudiesRecruitingShare
Not applicable3027.3%
Phase 13127.3%
Observational2218.2%
Phase 22218.2%
Phase 1/2119.1%

Most active sponsors

Lead sponsors with the most studies (Rheumatoid Arthritis (RA))
Lead sponsorStudiesRecruiting
Ancilia Biosciences10
Artiva Biotherapeutics, Inc.11
Eli Lilly and Company11
Fate Therapeutics11
Kyverna Therapeutics11
LAPIX Therapeutics Inc.10
Luminary Therapeutics10
SecondWave Systems Inc.10
Solarea Bio, Inc10
Sonoma Biotherapeutics, Inc.11

Top states

Top states (Rheumatoid Arthritis (RA)), by number of studies with a site there
StateStudies
California4
Florida4
Arizona3
Colorado3
Illinois3
Massachusetts3
Alabama2
Minnesota2
Pennsylvania2
Texas2
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.